Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HAO
HAO logo

HAO Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.060
Open
1.000
VWAP
1.00
Vol
237.22K
Mkt Cap
1.94M
Low
0.900
Amount
238.01K
EV/EBITDA(TTM)
--
Total Shares
1.85M
EV
-2.95M
EV/OCF(TTM)
--
P/S(TTM)
--
Haoxi Health Technology Ltd is a China-based holding company principally engaged in the provision of online marketing solutions for customers. The Company's main business is the provision of one-stop advertising marketing solutions like online short video advertisements through its media partners, including planning, production, placement, and optimization of online advertisements. The co-operative media partners of the Company include media platforms (such as Toutiao and Tiktok) and authorized third-party agent media. The Company principally provides its advertising services to companies and customers in the healthcare field. The Company principally conducts its businesses in the domestic market.
Show More

Events Timeline

(ET)
2026-05-20
19:50:00
Haoxi Health Technology Ltd Trading Halted, News Pending
select
2026-05-11 (ET)
2026-05-11
08:20:00
Haoxi Health Technology Enters $6.5M Securities Agreement with Investors
select
2026-03-03 (ET)
2026-03-03
07:40:00
Haoxi Health Signs Strategic Cooperation Agreement with Global Mofy AI
select
2025-04-21 (ET)
2025-04-21
09:53:32
Haoxi Health Technology launches customized livestreaming agency strategy
select
2025-02-11 (ET)
2025-02-11
07:49:05
Haoxi Health Technology regains compliance with Nasdaq closing bid price rule
select
2025-01-23 (ET)
2025-01-23
07:37:34
Haoxi Health Technology announces 1-for-25 reverse share split
select
2024-11-06 (ET)
2024-11-06
17:35:45
Haoxi Health Technology receives noncompliance letter from Nasdaq
select
2024-10-29 (ET)
2024-10-29
08:35:51
Haoxi Health Technology reports FY24 EPS 4c vs. 4c last year
select
2024-10-07 (ET)
2024-10-07
08:29:10
Haoxi Health Technology sees FY24 revenue $48.52M vs. $28.23M last year
select

News

Newsfilter
8.5
05-19Newsfilter
Haoxi Health Technology Announces Reverse Stock Split
  • Reverse Stock Split: Haoxi Health Technology announced a reverse stock split of its Class A and Class B ordinary shares at a ratio of 1-for-128, reducing the outstanding Class A shares from 235,504,007 to approximately 1,839,876 and Class B shares from 690,800 to about 5,397, which may impact shareholder equity and market liquidity.
  • Trading Schedule: The reverse stock split will take effect on May 21, 2026, with Class A shares trading on Nasdaq on an adjusted basis, aimed at increasing stock price; however, the company cannot guarantee that post-split prices will remain above pre-split levels, introducing uncertainty for investors.
  • Shareholder Guidance: Shareholders holding shares in book-entry form need not take action, as Transhare Corporation LLC will act as the exchange and paying agent, facilitating the stock conversion process and minimizing operational complexities associated with the split.
  • Company Overview: Haoxi Health Technology, based in Beijing, specializes in providing online marketing solutions for the healthcare sector, focusing on reducing costs and increasing efficiency through one-stop solutions like short video marketing, thereby strengthening its competitive position in the Chinese market as demand for healthcare advertising rises.
Newsfilter
8.5
05-12Newsfilter
Haoxi Health Technology Secures $6.5 Million in Direct Offering
  • Funding Size: Haoxi Health Technology successfully closed a $6.5 million registered direct offering through Univest Securities, selling 9 million Class A ordinary shares and 16,999,998 pre-funded warrants, indicating strong demand for its online marketing solutions in the healthcare sector.
  • Equity Structure: The offering priced shares at $0.25 each, with pre-funded warrants exercisable at $0.0026, reflecting investor confidence in the company's growth potential, which may enhance shareholder value.
  • Market Positioning: Haoxi focuses on short-form video and news feed advertising, leveraging the rapid growth of major Chinese digital platforms to provide one-stop online marketing solutions for healthcare clients, further solidifying its market leadership.
  • Strategic Partnership: Univest Securities acted as the sole placement agent, showcasing its influence in the capital markets and assisting Haoxi Health Technology in securing funding to drive business expansion and technological innovation.
Newsfilter
2.0
03-03Newsfilter
Haoxi Health and Eaglepoint AI Sign Strategic Cooperation Agreement
  • Strategic Cooperation Agreement: Haoxi Health and Eaglepoint AI have signed a three-year strategic cooperation agreement, committing joint R&D, data, and channel resources to launch an AI health management platform, marking Haoxi's exploration of new opportunities in the AI healthcare sector.
  • Innovative Technology Application: This collaboration represents the first deployment of Eaglepoint AI's Aquila data engine and multimodal model evaluation system in a health management scenario, expected to enhance the intelligence of health management and drive the development of preventive healthcare applications.
  • Market Promotion Support: Haoxi Health plans to leverage its extensive marketing networks to provide user reach and commercial conversion support, while Eaglepoint AI will handle technical support, including model training and data security compliance, ensuring smooth project execution.
  • Phase One Objectives: The initial phase will launch the
Yahoo Finance
3.0
2025-10-04Yahoo Finance
Concerns Arise Among Investors Regarding Haoxi Health Technology's (NASDAQ:HAO) Capital Returns
  • Haoxi Health Technology's Financial Performance: The company has a low return on capital employed (ROCE) of 4.1%, significantly below the media industry average of 9.5%, indicating underperformance despite an increase in capital employed and revenue.

  • Growth Strategy and Risks: Although Haoxi is reinvesting for growth, leading to higher sales, its stock has plummeted 82% over the past year, suggesting potential underlying issues, including five warning signs that investors should be aware of.

Benzinga
9.5
2025-09-11Benzinga
Oxford Industries Shares Rise Approximately 15%; Check Out 20 Stocks Making Moves in Premarket Trading
  • Oxford Industries Earnings Report: Oxford Industries, Inc. shares rose 15.1% in pre-market trading after reporting Q2 earnings of $1.26 per share, exceeding analyst expectations of $1.18, and raising its FY25 EPS guidance despite a revenue miss.

  • Pre-Market Stock Movements: Several stocks saw significant pre-market trading movements, with YY Group Holding Limited gaining 122.9% and Vince Holding Corp rising 101%, while Robin Energy Ltd. and TOP Financial Group Limited experienced declines of 23.5% and 21.6%, respectively.

Benzinga
2.0
2025-08-27Benzinga
MongoDB Shares Surge 31%; Check Out 20 Stocks Making Moves in Premarket Trading
  • MongoDB's Strong Performance: MongoDB, Inc. shares surged 31% in pre-market trading after reporting better-than-expected second-quarter results and raising its fiscal 2026 adjusted EPS guidance to between $3.64 and $3.73.

  • Other Gainers: Notable pre-market gainers included NovaBay Pharmaceuticals (up 66.7% due to a special cash dividend), Bollinger Innovations (up 32.1%), and BioXcel Therapeutics (up 19.5% after announcing Phase 3 data).

  • Pre-Market Losers: Stocks that declined in pre-market trading included Fenbo Holdings (down 16.8%), SCWorx Corp (down 15.2%), and Beneficient (down 14.3%).

  • Market Overview: The article provides a snapshot of various stocks' performances in pre-market trading, highlighting significant movements both upward and downward.

Valuation Metrics

The current forward P/E ratio for Haoxi Health Technology Ltd (HAO.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Haoxi Health Technology Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

under $20 stocks
Intellectia · 3048 candidates
Price: <= $20.00
Ticker
Name
Market Cap$
top bottom
HAO logo
HAO
Haoxi Health Technology Ltd
2.42M
EZGO logo
EZGO
EZGO Technologies Ltd
670.40K
ADTX logo
ADTX
Aditxt Inc
76.16K
PPCB logo
PPCB
Propanc Biopharma Inc
1.47M
LZMH logo
LZMH
LZ Technology Holdings Ltd
15.12M
MEHA logo
MEHA
Functional Brands Inc
2.13M

Whales Holding HAO

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Haoxi Health Technology Ltd (HAO) stock price today?

The current price of HAO is 1.05 USD — it has increased 2.94

What is Haoxi Health Technology Ltd (HAO)'s business?

Haoxi Health Technology Ltd is a China-based holding company principally engaged in the provision of online marketing solutions for customers. The Company's main business is the provision of one-stop advertising marketing solutions like online short video advertisements through its media partners, including planning, production, placement, and optimization of online advertisements. The co-operative media partners of the Company include media platforms (such as Toutiao and Tiktok) and authorized third-party agent media. The Company principally provides its advertising services to companies and customers in the healthcare field. The Company principally conducts its businesses in the domestic market.

What is the price predicton of HAO Stock?

Wall Street analysts forecast HAO stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HAO is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Haoxi Health Technology Ltd (HAO)'s revenue for the last quarter?

Haoxi Health Technology Ltd revenue for the last quarter amounts to 4.72 USD, increased 134.83

What is Haoxi Health Technology Ltd (HAO)'s earnings per share (EPS) for the last quarter?

Haoxi Health Technology Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does Haoxi Health Technology Ltd (HAO). have?

Haoxi Health Technology Ltd (HAO) has 26 emplpoyees as of May 31 2026.

What is Haoxi Health Technology Ltd (HAO) market cap?

Today HAO has the market capitalization of 1.94M USD.